Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients (Q44766608)

6 December 2017

title

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients (English)

1 reference

6 December 2017

1 reference

Bay JO

1

1 reference

6 December 2017

Fleury J

2

1 reference

6 December 2017

Choufi B

3

1 reference

6 December 2017

Tournilhac O

4

1 reference

6 December 2017

Vincent C

5

1 reference

6 December 2017

Bailly C

6

1 reference

6 December 2017

Dauplat J

7

1 reference

6 December 2017

Viens P

8

1 reference

6 December 2017

Faucher C

9

1 reference

6 December 2017

Blaise D

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

30

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

95-102

1 reference

Management of ovarian carcinoma. Current concepts and future prospects

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Nonablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

Chemotherapy of ovarian cancer. New approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Female genital tract cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Long-term follow-up of T-cell depletion for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1703609

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703609

1 reference

Dimensions Publication ID

6 December 2017

1042420376

0 references

1 reference